Issue 19, 2018

Peroxoniobium inhibits leukemia cell growth

Abstract

A new class of polyoxoniobate complex has been synthesized and characterized as a novel anticancer agent for photodynamic therapy. The complex inhibits the growth of chronic myelogenous leukemia cells with an IC50 value of 30 μM, in the dark. However, upon exposure to light (365 nm) there is a fivefold increase in the cytotoxic activity. Light radiation activate the complex with the formation of radical species capable of interacting with DNA according to our experimental and theoretical data.

Graphical abstract: Peroxoniobium inhibits leukemia cell growth

Supplementary files

Article information

Article type
Paper
Submitted
29 Janv. 2018
Accepted
08 Marts 2018
First published
14 Marts 2018
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2018,8, 10310-10313

Peroxoniobium inhibits leukemia cell growth

E. C. Pereira-Maia, I. P. Souza, K. J. R. C. Nunes, A. A. Castro, T. C. Ramalho, F. Steffler, H. A. Duarte, A. Pacheli, P. Chagas and L. C. A. Oliveira, RSC Adv., 2018, 8, 10310 DOI: 10.1039/C8RA00898A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements